Clinical Trial: Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289503) titled 'Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above' on Dec. 04.

Brief Summary: The primary objective of this study is to evaluate the tolerability, reactogenicity and safety of a single injection of three dose levels of ABO1105 in adults aged 18 years or above.

Study Start Date: May 27

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus

Intervention: BIOLOGICAL: ABO1105

Formulation for injection

DRUG: Placebo

0.9% sodium chloride (normal saline) injection

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Suzhou Abogen Biosciences Co., Ltd.

Publis...